Synchronous and metachronous metastases contribute to the high mortality of CRC and, despite improvements in the management of metastatic CRC, 5-year mortality remains up to 50% with a worse outcome for synchronous versus metachronous metastasis (5-year relative survival 7.2% versus 17.6%). Colorectal cancer (CRC) is the second most common cancer in Europe and the USA.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |